95
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Association between circulating microRNA-126 expression level and tumour necrosis factor alpha in healthy smokers

ORCID Icon, ORCID Icon, ORCID Icon &
Pages 469-477 | Received 20 Oct 2018, Accepted 17 Apr 2019, Published online: 08 May 2019

References

  • Bagheri, A., et al., 2019. A panel of noncoding RNAs in non-small‐cell lung cancer. Journal of cellular biochemistry, 120 (5), 8280–8290.
  • Banerjee, A., et al., 2015. Quantification of plasma microRNAs in a group of healthy smokers, ex-smokers and non-smokers and correlation to biomarkers of tobacco exposure. Biomarkers, 20 (2), 123–131.
  • Bartel, D.P., 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116 (2), 281–297.
  • Busk, P.K., 2014. A tool for design of primers for microRNA-specific quantitative RT-qPCR. BMC bioinformatics, 15, 29.
  • Chen, T., 2010. The role of MicroRNA in chemical carcinogenesis. Journal of environmental science and health, part C, 28 (2), 89–124.
  • Chen, H., et al., 2014. Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A. Oncotarget, 5 (23), 11873–11885.
  • Control, C.F.D, & Prevention 2008. Smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 2000–2004. MMWR, 57, 1226–1228.
  • Cordes, K.R., and Srivastava, D., 2009. MicroRNA regulation of cardiovascular development. Circulation research, 104 (6), 724–732.
  • DE Ronde, M.W., et al., 2017. High miR-124-3p expression identifies smoking individuals susceptible to atherosclerosis. Atherosclerosis, 263, 377–384.
  • DE Simone, V., et al., 2015. Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth. Oncogene, 34 (27), 3493.
  • Dennis, G., et al., 2003. DAVID: database for annotation, visualization, and integrated discovery. Genome biology, 4 (9), R60.
  • Díez, J.P., et al., 2012. Tumor necrosis factor as an early marker of inflammation in healthy smokers. Medicina clinica, 139, 47–53.
  • Dorsam, R.T., and Gutkind, J.S., 2007. G-protein-coupled receptors and cancer. Nature reviews cancer, 7 (2), 79.
  • Dweep, H., et al., 2011. miRWalk–database: prediction of possible miRNA binding sites by “walking” the genes of three genomes. Journal of biomedical informatics, 44 (5), 839–847.
  • Erhardt, L., 2009. Cigarette smoking: an undertreated risk factor for cardiovascular disease. Atherosclerosis, 205 (1), 23–32.
  • Fish, J.E., et al., 2008. miR-126 regulates angiogenic signaling and vascular integrity. Developmental cell, 15 (2), 272–284.
  • Hara, T., et al., 2014. Selective targeting of KRAS-mutant cells by miR-126 through repression of multiple genes essential for the survival of KRAS-mutant cells. Oncotarget, 5 (17), 7635.
  • Harris, T.A., et al., 2008. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proceedings of the national academy of sciences of the United States of America, 105 (5), 1516–1521.
  • Hoffmann, D., Hoffmann, I., and EL-Bayoumy, K., 2001. The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder. Chemical research in toxicology, 14 (7), 767–790.
  • Huang, Z., et al., 2010. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. International journal of cancer, 127 (1), 118–126.
  • Izzotti, A., et al., 2009a. Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB journal, 23 (3), 806–812.
  • Izzotti, A., et al., 2009b. Relationships of microRNA expression in mouse lung with age and exposure to cigarette smoke and light. Faseb journal, 23 (9), 3243–3250.
  • Jackman, D.M., and Johnson, B.E., 2005. Small-cell lung cancer. Lancet (London, England)), 366 (9494), 1385–1396.
  • Kalscheuer, S., et al., 2008. Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis, 29 (12), 2394–2399.
  • Kato, R., et al., 2016. Sirt1 expression is associated with CD31 expression in blood cells from patients with chronic obstructive pulmonary disease. Respiratory research, 17, 139.
  • Koubaa, A., et al., 2015. Changes in antioxidant defense capability and lipid profile after 12-week low-intensity continuous training in both cigarette and hookah smokers: a follow-up study. PloS one, 10 (6), e0130563.
  • Lao, X.Q., et al., 2009. Smoking, smoking cessation and inflammatory markers in older Chinese men: The Guangzhou Biobank Cohort Study. Atherosclerosis, 203 (1), 304–310.
  • Lin, X., et al., 2017. Correlation between tumor necrosis factor-α and interleukin-1β in exhaled breath condensate and pulmonary function. American journal of the medical sciences, 354 (4), 388–394.
  • Liu, Y., et al., 2014. The role of circulating microRNA-126 (miR-126): a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus. International journal of molecular sciences, 15 (6), 10567–10577.
  • Loffredo, C.A., et al., 2015. Estimates of the prevalence of tobacco smoking in Egypt. Open journal of epidemiology, 05 (02), 129.
  • Makeyev, E.V., et al., 2007. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Molecular cell, 27 (3), 435–448.
  • Markou, A., et al., 2013. Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 81 (3), 388–396.
  • Mateu-Jimenez, M., et al., 2018. Profile of epigenetic mechanisms in lung tumors of patients with underlying chronic respiratory conditions. Clinical epigenetics, 10, 7.
  • Mcallister, D.A., et al., 2007. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine, 176 (12), 1208–1214.
  • Mirhafez, S.R., et al., 2015. Relationship between serum cytokine and growth factor concentrations and coronary artery disease. Clinical biochemistry, 48 (9), 575–580.
  • Mostert, B., et al., 2011. Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients. Expert review of molecular diagnostics, 11 (3), 259–275.
  • Nana-Sinkam, S.P., et al., 2009. Lung microRNA: from development to disease. Expert review of respiratory medicine, 3 (4), 373–385.
  • Petrescu, F., Voican, S.C., and Silosi, I., 2010. Tumor necrosis factor-α serum levels in healthy smokers and nonsmokers. International journal of chronic obstructive pulmonary disease, 5, 217.
  • Rizk, S.A., et al., 2018. Down-regulation of circulating microRNA let-7a in Egyptian smokers. Journal of genetic engineering and biotechnology, 16 (1), 53–56.
  • Sanfiorenzo, C., et al., 2013. Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. PloS one, 8 (1), e54596.
  • Santarelli, L., et al., 2019. Four-miRNA signature to identify asbestos-related lung malignancies. Cancer epidemiology biomarkers & prevention, 28 (1), 119–126.
  • Schmittgen, T.D., and Livak, K.J., 2008. Analyzing real-time PCR data by the comparative CT method. Nature protocols, 3 (6), 1101–1108.
  • Serban, K.A., et al., 2016. Structural and functional characterization of endothelial microparticles released by cigarette smoke. Scientific reports, 6, 31596.
  • Shigdar, S., et al., 2014. Inflammation and cancer stem cells. Cancer letters, 345 (2), 271–278.
  • Small, E.M., Frost, R.J., and Olson, E.N., 2010. MicroRNAs add a new dimension to cardiovascular disease. Circulation, 121 (8), 1022–1032.
  • Söderlin, M., Petersson, I., and Geborek, P., 2012. The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug. Scandinavian journal of rheumatology, 41 (1), 1–9.
  • Song, L., et al., 2016. MicroRNA-126 targeting PIK3R2 inhibits NSCLC A549 cell proliferation, migration, and invasion by regulation of PTEN/PI3K/AKT pathway. Clinical lung cancer, 17 (5), e65–e75.
  • Sugiura, T., et al., 2015. Circulating level of microRNA-126 may be a potential biomarker for recovery from smoking-related vascular damage in middle-aged habitual smokers. IJC heart & vasculature, 7, 83–87.
  • Sun, Y., et al., 2010. miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7. Biochemical and biophysical research communications, 391 (3), 1483–1489.
  • Taganov, K.D., et al., 2006. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proceedings of the national academy of sciences of the United States of America, 103 (33), 12481–12486.
  • Takahashi, K., et al., 2013. Cigarette smoking substantially alters plasma microRNA profiles in healthy subjects. Toxicology and applied pharmacology, 272 (1), 154–160.
  • Tomasetti, M., et al., 2012. Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients. Clinical biochemistry, 45 (7–8), 575–581.
  • Ulivi, P., et al., 2019. Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer. Journal of clinical medicine, 8 (2), 131.
  • Wang, S., et al., 2008. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Developmental cell, 15 (2), 261–271.
  • Wang, Z., et al., 2018. Identification of candidate genes or microRNAs associated with the lymph node metastasis of SCLC. Cancer cell international, 18, 161
  • Wannamethee, S.G., et al., 2005. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. European heart journal, 26 (17), 1765–1773.
  • Yanaihara, N., et al., 2006. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer cell, 9 (3), 189–198.
  • Zernecke, A., et al., 2009. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Science signaling, 2 (100), ra81
  • Zhang, J., et al., 2018. Estrogen‐related receptor alpha triggers the proliferation and migration of human non‐small cell lung cancer via interleukin‐6. Cell biochemistry and function, 36, 255–262.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.